151 related articles for article (PubMed ID: 12384636)
21. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
Okmen E; Cakmak M; Tartan Z; Cam N
Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
[TBL] [Abstract][Full Text] [Related]
22. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
De Luca G; Marino P
Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
[TBL] [Abstract][Full Text] [Related]
23. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
24. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein IIb/IIIa antagonists: do they have a role in the management of unstable angina?
Redwood S; Marber M; Jackson G
Int J Clin Pract; 1999 Dec; 53(8):618-22. PubMed ID: 10692757
[TBL] [Abstract][Full Text] [Related]
26. Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study.
Huynh T; Piazza N; DiBattiste PM; Snapinn SM; Wan Y; Pharand C; Theroux P
Int J Cardiol; 2005 Apr; 100(1):73-8. PubMed ID: 15820288
[TBL] [Abstract][Full Text] [Related]
27. [Antithrombotic therapy for non-ST segment elevation myocardial infarction].
Hölschermann H
Hamostaseologie; 2006 May; 26(2):106-13. PubMed ID: 16676052
[TBL] [Abstract][Full Text] [Related]
28. Proper use of glycoprotein IIb/IIIa inhibitors in patients with non-sT elevation acute coronary syndromes undergoing coronary angiography: frankly, my dear, I don't give a damn.
Bovenzi F; De Luca L
J Cardiovasc Med (Hagerstown); 2006 Mar; 7(3):166-8. PubMed ID: 16645380
[No Abstract] [Full Text] [Related]
29. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
Lee DS; Bhatt DL; Moliterno DJ; Peacock WF; Ellis SG; Topol EJ
J Invasive Cardiol; 2004 Feb; 16(2):46-51. PubMed ID: 14760188
[TBL] [Abstract][Full Text] [Related]
30. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
31. [Abciximab (ReoPro) in the treatment of acute coronary syndromes].
Rasmussen LH; Husted SE; Kassis E; Kastrup J; Kristensen SD; Pedersen KE; Grande P
Ugeskr Laeger; 2001 Jan; 163(4):472-7. PubMed ID: 11218792
[TBL] [Abstract][Full Text] [Related]
32. Results of IIb/IIIa receptor blockade in patients with unstable angina.
Vahanian A; Michaud P; Garbarz E
Semin Interv Cardiol; 1999 Jun; 4(2):61-6. PubMed ID: 10473874
[TBL] [Abstract][Full Text] [Related]
33. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.
Goa KL; Noble S
Drugs; 1999 Mar; 57(3):439-62. PubMed ID: 10193692
[TBL] [Abstract][Full Text] [Related]
34. Anti-GPIIb/IIIa drugs: current strategies and future directions.
Coller BS
Thromb Haemost; 2001 Jul; 86(1):427-43. PubMed ID: 11487034
[TBL] [Abstract][Full Text] [Related]
35. Guidelines for the early management of acute coronary syndromes: focus on antithrombotic and antiplatelet therapy.
Fitchett D;
Can J Cardiol; 2000 Nov; 16(11):1423-32. PubMed ID: 11109039
[TBL] [Abstract][Full Text] [Related]
36. Management of unstable angina and non-ST-segment elevation myocardial infarction.
Hanley HG; Nylk TM; Nguyen N
J La State Med Soc; 2001 Jun; 153(6):306-11. PubMed ID: 11480381
[TBL] [Abstract][Full Text] [Related]
37. Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
Roffi M; Chew DP; Mukherjee D; Bhatt DL; White JA; Moliterno DJ; Heeschen C; Hamm CW; Robbins MA; Kleiman NS; Théroux P; White HD; Topol EJ
Eur Heart J; 2002 Sep; 23(18):1441-8. PubMed ID: 12208224
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
Jafary FH; Kimmelstiel CD
J Thromb Thrombolysis; 2000 Feb; 9(2):163-74. PubMed ID: 10613998
[No Abstract] [Full Text] [Related]
39. [Treatment of unstable coronary disease].
Préda I
Orv Hetil; 2002 Apr; 143(15):757-65. PubMed ID: 11979994
[TBL] [Abstract][Full Text] [Related]
40. Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction.
Crosbie DJ
Emerg Med Australas; 2005; 17(5-6):500-10. PubMed ID: 16302944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
